NCT05570929 LONGitudinal Multi-omics Phenotyping of KIDney Function Alteration
| NCT ID | NCT05570929 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Charite University, Berlin, Germany |
| Condition | Chronic Kidney Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2023-02-07 |
| Primary Completion | 2025-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2023-02-07 with a primary completion date of 2025-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a longitudinal observation of kidney function, immune system and gut microbiota before and 24 weeks after a live kidney transplantation conducted in donor and recipient pairs living in the same household. Outcome measures include kidney function, body composition, blood pressure, gut microbiome composition, metabolomics and immune cell states.
Eligibility Criteria
Inclusion Criteria: * Body-Mass-Index 18,5 - 34,9 kg/m2 * Planned living kidney donation / transplantation Exclusion Criteria: * Clinically relevant heart, lung, liver, and kidney diseases * Postoperative phase * Acute infections * Vegan diet * Change of body weight of more than 10% in the month prior to study entry * Known drug or alcohol abuse
Contact & Investigator
Nicola Wilck, MD
PRINCIPAL INVESTIGATOR
Charite University, Berlin, Germany
Frequently Asked Questions
Who can join the NCT05570929 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Chronic Kidney Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05570929 currently recruiting?
Yes, NCT05570929 is actively recruiting participants. Contact the research team at hendrik.bartolomaeus@charite.de for enrollment information.
Where is the NCT05570929 trial being conducted?
This trial is being conducted at Berlin, Germany.
Who is sponsoring the NCT05570929 clinical trial?
NCT05570929 is sponsored by Charite University, Berlin, Germany. The principal investigator is Nicola Wilck, MD at Charite University, Berlin, Germany. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.